Associated Papers
The Occurrence of Gene Fusions in Thyroid Lesions and the Relation With Chronic Lymphocytic Thyroiditis.
Jentus MM et al.
Pathology International, 2026
41492106 (PubMed )
Supplement: PIN-76-0-s003.docx
Molecular Characterization of Advanced-Stage Melanomas in Clinical Practice Using a Laboratory-Developed Next-Generation Sequencing Panel.
Maloberti T et al.
Diagnostics (basel, Switzerland), 2024
38667446 (PubMed )
Supplement: diagnostics-14-00800-s001.zip › Supplementary_Table_S1.xlsx › Foglio1
Aberrant EVI1 splicing contributes to EVI1-rearranged leukemia.
Tanaka A et al.
Blood, 2022
35709354 (PubMed )
Supplement: 10.1182-2021015325_bloodbld2021015325-suppl1.pdf
Recurrent PTPN14 Mutations in Trichilemmoma: Evidence for Distinct Pathways of Molecular Pathogenesis.
Russell-Goldman E et al.
The American Journal of Dermatopathology, 2022
Detection of TERT Promoter Mutations Using Targeted Next-Generation Sequencing: Overcoming GC Bias through Trial and Error.
Lee H et al.
Cancer Research and Treatment, 2022
33940787 (PubMed )
Supplement: crt-2021-107_S3_Table.pdf
TERT Promoter Mutations and Their Impact on Gene Expression Profile in Papillary Thyroid Carcinoma.
Rusinek D et al.
Cancers, 2020
32560331 (PubMed )
Supplement: cancers-12-01597-s001.zip › Table_S2.xlsx › Supplementary_Table_2
An update on molecular alterations in melanocytic tumors with emphasis on Spitzoid lesions.
Dimonitsas E et al.
Annals of Translational Medicine, 2018
Towards Personalized Medicine in Melanoma: Implementation of a Clinical Next-Generation Sequencing Panel.
de Unamuno Bustos B et al.
Scientific Reports, 2017
28356599 (PubMed )
Supplement: 41598_2017_606_MOESM2_ESM.xls › Table_S1
Select a paper to view details